Ignite Creation Date:
2024-05-05 @ 11:28 PM
Last Modification Date:
2024-10-26 @ 10:34 AM
Study NCT ID:
NCT01339650
Status:
COMPLETED
Last Update Posted:
2018-01-02
First Post:
2011-04-04
Brief Title:
Study of ABT-767 in Subjects With Breast Cancer 1 and Breast Cancer 2 BRCA 1 and BRCA 2 Mutations and Solid Tumors or High Grade Serous Ovarian Fallopian Tube or Primary Peritoneal Cancer
Sponsor:
Organization:
AbbVie
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
93
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE1 |
Observational Models:
Time Perspective List:
Who Masked List: